SA
CAHPF logo
Evolution Mining Limited(CAHPF)
Closing price · checked 10:21 PM ETAbout this dataData status
$7.79▼-0.70 (-8.30%)
Pre-Market:$7.71-0.08 (-1.03%)· 10:21 PM ET

S&P 500, Nasdaq, Russell 2000 below the 200-day average (VIX 22.6)

Overview →

Consensus

No ratings0 ratings
1 rating older than 2 years not counted

Price vs analyst targets

Revenue and EPS estimates

Consensus estimates
Fiscal periodFY2015Jun '15FY2016Jun '16FY2017Jun '17FY2018Jun '18FY2019Jun '19FY2020Jun '20FY2021Jun '21FY2022Jun '22FY2023Jun '23FY2024Jun '24FY2025Jun '25FY2026Jun '26FY2027Jun '27FY2028Jun '28FY2029Jun '29FY2030Jun '30FY2031Jun '31
Revenue (B)0.671.321.471.521.521.891.872.032.243.174.355.525.536.286.557.136.68
Growth YoY–+97.8%+11.1%+3.7%−0.4%+24.7%−1.0%+8.2%+10.3%+41.8%+37.2%+26.7%+0.3%+13.6%+4.2%+8.9%−6.4%
High estimate0.761.501.671.731.722.152.122.302.533.594.455.726.246.987.327.987.47
Low estimate0.601.181.311.361.361.691.671.812.002.834.185.405.045.425.806.315.91
Analysts713971397139715161616887
EPS, adjusted0.110.160.160.150.130.210.200.150.120.210.460.790.851.031.081.190.94
Growth YoY–+41.4%+4.7%−6.0%−14.9%+62.8%−4.6%−25.7%−21.3%+78.2%+116.5%+70.6%+7.5%+22.0%+4.6%+10.6%−20.9%
High estimate0.130.180.190.180.150.250.240.180.140.250.530.910.981.191.251.381.09
Low estimate0.100.140.140.130.110.180.180.130.100.180.390.670.720.880.921.020.80
Analysts11111111111111111

Consensus mean of analyst estimates. EPS is adjusted (street) EPS, the basis analysts forecast; annual actuals are the sum of the four reported quarters. Growth compares with the same period a year earlier; n/m where the prior period was a loss.

Brokers

2 firms active in the last 12 months
FirmAnalystRatingPrev ratingTargetPrev targetChgUpsideDate
Canaccord Genuity–––$12.25–––Jul 15
Goldman SachsHugo NicolaciSell · Jul 2021 · not countedNeutral$12.70–––Jun 3

Latest analyst action Page refreshed hourly; analyst feeds refreshed dailyAbout this data

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.